Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DRD1 suppresses cell proliferation and reduces EGFR activation and PD‐L1 expression in NSCLC

4 Apr 2024

Abstract excerpt

Dopamine (DA) acts in various key neurological and physiological processes as both a neurotransmitter and circulating hormone. Over the past several decades, the DA signaling network has been shown to regulate the progression of several types of solid tumors, and considerable evidence has shown it is a druggable pathway in the cancer cell context. However, the specific activity and effect of these pathway...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Stress, Anesthesia, and Immune Response
Share to Epigenetics and DNA Methylation
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38572507
DOI: 10.1002/1878-0261.13608

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DRD1 suppresses cell proliferation and reduces EGFR activation and PD‐L1 expression in NSCLCPMID 38572507Read ↗

Genetic and Functional Analysis of Polymorphisms in the Human Dopamine Receptor and Transporter Genes in Small Cell Lung Cancer.Semantic proximity Read ↗

DARPP-32 and t-DARPP promote lung cancer growth through IKKα-dependent cell migration and Akt/Erk-mediated cell survivalSemantic proximity Read ↗

Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5Semantic proximity Read ↗

Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastomaSemantic proximity Read ↗

The Activation of p300 Enhances the Sensitivity of Pituitary Adenomas to Dopamine Agonist Treatment by Regulating the Transcription of DRD2Semantic proximity Read ↗

Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 AntagonismSemantic proximity Read ↗

Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis.Semantic proximity Read ↗

Polymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancer.Semantic proximity Read ↗

Repurposing Diphenhydramine in Non-Small Cell Lung Cancer: A Mitochondrial Redox Mechanism and a Derived Prognostic Gene SignatureSemantic proximity Read ↗

NeuroD1 mediates nicotine-induced migration and invasion via regulation of the nicotinic acetylcholine receptor subunits in a subset of neural and neuroendocrine carcinomas.Semantic proximity Read ↗

ASCL1-regulated DARPP-32 and t-DARPP stimulate small cell lung cancer growth and neuroendocrine tumor cell survivalSemantic proximity Read ↗

MiR-140 Expression Regulates Cell Proliferation and Targets PD-L1 in NSCLCSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.